首页> 外国专利> A NOVEL THROMBOPOIETIN SIGNALING DEFECT IN POLYCYTHEMIA VERA PLATELETS

A NOVEL THROMBOPOIETIN SIGNALING DEFECT IN POLYCYTHEMIA VERA PLATELETS

机译:血小板增多症血小板中新的凝血酶生成素信号缺陷

摘要

Impaired TPO-mediated platelet protein tyrosine phosphorylation was consistently observed in patients with polycythemia vera (PV) as well as those with idiopathic myelofibrosis (IMF). The platelet TPO receptor, Mpl, was not detectable by immunoblotting with an antibody to the extracellular domain, by chemical cross-linking of TPO to the surface of platelets, or by flow cytometry using an antibody to the extracellular domain. Impaired TPO-induced protein tyrosine phosphorylation in PV and IMF platelets was uniformly associated with markedly reduced or absent expression of the extracellular domain of Mpl. Thus the reduced detectability of Mpl can be used as a marker of PV and IMF. The abnormality appears to distinguish PV from other forms of erythrocytosis and may be involved in the platelet function defect associated with PV.
机译:在真性红细胞增多症(PV)和特发性骨髓纤维化(IMF)患者中始终观察到TPO介导的血小板蛋白酪氨酸磷酸化受损。通过用针对细胞外结构域的抗体免疫印迹,通过TPO与血小板表面的化学交联或使用针对细胞外结构域的抗体的流式细胞术检测不到血小板TPO受体Mpl。 PV和IMF血小板中TPO诱导的蛋白酪氨酸磷酸化受损与Mpl胞外域表达的明显降低或缺乏一致相关。因此,降低的Mpl的可检测性可以用作PV和IMF的标记。异常似乎使PV与其他形式的红细胞增多症区分开,并且可能与PV相关的血小板功能缺陷有关。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号